Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
05/1998
05/12/1998US5750539 Antiasthmatics
05/12/1998US5750521 Mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/12/1998US5750137 Drug delivery, permeability, glycerides and lactates
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018482A1 Use of lh-rh antagonists as diagnostic agent
05/07/1998WO1998005323A3 Method of regulating the female reproductive system through angiogenesis inhibitors
05/07/1998DE19644994A1 Diagnostisches Mittel Diagnostic agent
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/06/1998EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue
05/06/1998EP0839831A2 Single chain gonadotropin
05/06/1998EP0839145A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents
05/06/1998EP0839144A1 Piperazine derivatives as therapeutic agents
05/06/1998EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases
05/06/1998EP0839040A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence
05/06/1998EP0788364A4 Treatment of urogenital cancer with boron neutron capture therapy
05/06/1998EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
05/06/1998CN1181084A Tricyclic benzazepine vasopression antagonists
05/06/1998CN1181019A Combination compositions containing benazepril or beazeprilat and valsartan
05/06/1998CN1181016A Use of hyaluronic acid for the treatment of interstitial cystitis
05/06/1998CN1181011A Combined hormonal contraception pharmaceutical perparation
05/05/1998US5747659 Increased egg lay; fertility agents
05/05/1998US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them
05/05/1998US5747318 Mitogen activated c-Fos regulating kinase, FRK
05/05/1998US5747065 Monoglyceride/lactate ester permeation enhancer for oxybutynin
05/05/1998US5747059 Diphenylchromans
05/05/1998US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
05/05/1998CA2097589C Targeting of therapeutic agents using polysaccharides
04/1998
04/30/1998WO1998017668A1 Thienopyrimidine with phosphodiesterase v inhibiting effect
04/30/1998DE19644228A1 Thienopyrimidine Thienopyrimidines
04/29/1998EP0838523A2 RsbW-1 derived from Staphylococcus
04/29/1998EP0838221A1 Lyophilized hgf preparations
04/29/1998EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque
04/29/1998EP0837681A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
04/29/1998CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
04/29/1998CN1180351A Benzothiazine dioxides as endothelin antagonists
04/29/1998CN1180311A Use of 'alpha' 1L agonists in treatment of incontinence
04/29/1998CN1179971A Traditional Chinese medicine for curing leukoplakia vulvae of gynecopathy
04/29/1998CN1179942A Long-acting subcutaneous contraceptive implanting agent containing pregnadienone
04/29/1998CA2214866A1 Novel spo-rel
04/28/1998US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives
04/28/1998US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
04/28/1998US5744488 Indole derivatives thromboxane A2 antagonists
04/28/1998US5744474 Administering venlafaxine or duloxetine; treating stress, urge and/or nocturnal urinary incontinence
04/28/1998US5744464 Dysmennhorea
04/28/1998US5744448 Human follicle stimulating hormone receptor
04/28/1998CA2203621C Use of hyaluronic acid for the treatment of interstitial cystitis
04/23/1998WO1998016521A1 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
04/23/1998WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016224A1 Pyrazolinones to treat disturbances of potency
04/23/1998WO1998009170A3 Methods and compositions for the detection of cervical cancer
04/23/1998CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998CA2268823A1 Pyrazolinones to treat disturbances of potency
04/22/1998EP0837129A1 Epimorphin antagonist and process for producing the same
04/22/1998EP0837073A1 Human mad proteins and uses thereof
04/22/1998EP0836506A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
04/22/1998EP0721467A4 Use of relaxin as an analgesic and palliative for intractable pain
04/22/1998CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity
04/22/1998CN1179418A Novel cyloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
04/22/1998CN1179327A Medicine for treating woman's dysmenorrhea and preparing process thereof
04/22/1998CN1179308A Injection for castrating animals
04/21/1998US5741892 Pentapeptides as antitumor agents
04/21/1998US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma
04/21/1998US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders
04/21/1998US5741786 Steroids with a 17-spiromethylene lactone or lactol group
04/21/1998US5741776 Method of administration of IGF-I
04/16/1998WO1998015521A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis
04/16/1998WO1998015279A1 Hormonal composition consisting of an oestrogen compound and of a progestational compound
04/16/1998DE19642451A1 Aminothiophencarbonsäureamide Aminothiophencarbonsäureamide
04/16/1998DE19642284A1 Pyrazolinone zur Behandlung von Potenzstörungen Pyrazolinones for the treatment of erectile dysfunction
04/16/1998CA2267129A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis
04/15/1998EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
04/15/1998EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex
04/15/1998EP0835264A1 Human g-protein receptor hcegh45
04/15/1998EP0835107A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
04/15/1998EP0835106A1 Method of treating renal disease using an ace inhibitor and an aii antagonist
04/15/1998CN1178684A Chinese patent medicine for curing habitual abortion
04/15/1998CN1178677A Luteotropic preparation for parturient women and its producing technology
04/14/1998US5739138 Modulators of cellular response
04/14/1998US5739124 Administering an amine-containing estratriene
04/14/1998US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity
04/10/1998CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods
04/09/1998WO1998014596A2 Disease associated protein tyrosine phosphatases
04/09/1998CA2265449A1 Disease associated protein tyrosine phosphatases
04/08/1998EP0834565A2 A G-protein coupled receptor HUVCT36
04/08/1998EP0833845A1 Compounds with growth hormone releasing properties
04/08/1998EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations
04/08/1998EP0833658A1 Inhibin compositions and methods of enhancing production performance
04/08/1998EP0833650A1 P-selectin ligands and related molecules and methods
04/08/1998EP0833637A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
04/08/1998EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
04/08/1998CN1178532A Tricyclic vasopressin antagonists
04/08/1998CN1178463A Use of anti-oestrogens as male contraceptives
04/08/1998CN1037966C Production of 4 -(5, 6, 7, 8 -tetrahydroimidazo £1.5-a| pyridine -5 -group) benzonitrile acidified hemihydrate
04/07/1998US5736564 Endothelin receptor antagonists
04/07/1998US5736562 Modify function of serotonin in mammals
04/07/1998US5736143 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
04/02/1998WO1998013369A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
04/02/1998WO1998013366A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
04/02/1998CA2265950A1 Spiro-azacyclic derivatives and their use as therapeutic agents